New promise for drugs against difficult targets

Salipro awarded European patent for direct extraction of membrane proteins and library generation
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

STOCKHOLM—Swedish company Salipro Biotech AB recently announced that the European Patent Office had issued European Patent No. 3463303, titled “Saposin lipoprotein particles and libraries from crude membranes.” The patent covers the company’s novel method of direct extraction of membrane proteins (DirectMX) from cells or crude membranes to enable drug development for challenging drug targets, as well as for the generation of libraries with Salipro particles representing the membrane proteome, the particles themselves, and their uses.

The key application is in drug discovery, where membrane proteins represent the targets of more than 60 percent of drugs in clinical use. However, progress in drug development is often hampered by the inherent instability of membrane proteins—a major problem which is reportedly addressed by the Salipro platform’s ability to stabilize those important drug targets.

“Ever since its inception, DirectMX has had a profound impact on how we accelerate drug discovery with our pharma partners,” said Jens Frauenfeld, the company’s CEO. “Our foundational IP covering the Salipro platform technology has already resulted in various patents being granted to Salipro Biotech in the US, EU, China, and Japan, and this patent will provide additional broad protection for our proprietary platform technology for the stabilization of challenging drug targets.”

Added Salipro’s business developer, Maria Knudsen: “DirectMX is rapidly becoming established as a key drug discovery platform and we are already partnering with major pharma companies on a range of targets, including GPRCs, SLCs, and ion channels. Further strengthening our patent portfolio will enable us to increase the value of such collaborations as well as moving towards building our own discovery pipeline.”

Related Topics

Published In

Volume 17 - Issue 4 | April 2021

April 2021

April 2021 issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue